Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,07 EUR | -1,83% |
|
-6,96% | -89,14% |
17/06 | Aggiornamento settoriale: i titoli del settore sanitario scendono lunedì prima del mercato | MT |
17/06 | I principali ribassisti del mercato premarket | MT |
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics for Rare Seizures
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/09/18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12/04/21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06/11/19 |
Chief Tech/Sci/R&D Officer | - | - | |
Sonya Weigle
IRO | Public Communications Contact | - | 01/09/21 |
Christy Shafer
PRN | Corporate Officer/Principal | 48 | 10/11/20 |
General Counsel | - | - | |
Thomas Lyons
PRN | Corporate Officer/Principal | - | 01/01/18 |
Alex Aimetti
PRN | Corporate Officer/Principal | - | - |
Martha Manning
LAW | General Counsel | 69 | 15/06/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01/12/08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/09/18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12/12/19 |
Seth Fischer
BRD | Director/Board Member | 68 | 06/09/16 |
Sara Nochur
BRD | Director/Board Member | 63 | 22/03/21 |
Sarah Noonberg
BRD | Director/Board Member | 56 | 16/05/23 |
Director/Board Member | 41 | 26/01/23 | |
Charles Austin
BRD | Director/Board Member | 68 | 29/07/20 |
Marvin Johnson
BRD | Director/Board Member | 61 | 18/04/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 54 941 081 | 54 312 820 ( 98,86 %) | 7 307 ( 0,0133 %) | 98,86 % |
Coordinate società
Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center 100 Matsonford Road
19087-5279, Radnor
+484 801 4670
http://www.marinuspharma.com![Indirizzo Marinus Pharmaceuticals, Inc.(61Y)](https://cdn.zonebourse.com/static/address/50919091.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+56,89% | 823 Mrd | |
+39,52% | 627 Mrd | |
-6,55% | 353 Mrd | |
+15,99% | 320 Mrd | |
+7,92% | 295 Mrd | |
+13,74% | 239 Mrd | |
+13,83% | 220 Mrd | |
-0,49% | 219 Mrd | |
+7,94% | 167 Mrd |
- Borsa valori
- Azioni
- Azione MRNS
- Azione 61Y
- Società Marinus Pharmaceuticals, Inc.